The Biden administration announced Wednesday (Oct. 6) that it plans to invest an additional $1 billion in at-home rapid COVID-19 testing to expand manufacturing capabilities and increase test access, with the goal of quadrupling the amount of at-home tests on the market by the end of next year. Between the administration’s $1 billion investment and FDA’s recent authorization of ACON Laboratories’ over-the-counter at-home test , the availability of at-home tests could go up to 200 million per month by December,...